Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How would you treat a head and neck patient who had definitive chemoradiation who develops an isolated mediastinal lymph node recurrence?
Do you offer definitive treatment?
Systemic therapy alone since it's metastatic?
Answer from: Radiation Oncologist at Academic Institution
45 Gy/25 fx to mediastinum and boost to positive node to 65 to 70 Gy.
Comments
Radiation Oncologist at Karmanos Cancer Institute - McLaren Proton Therapy Center
I agree with Dr. @William M. Mendenhall, treat for...
5546
Sign In
or
Register
to read more
11759
Related Questions
How do you approach postoperative radiation therapy in a patient with head and neck cancer who has high risk of recurrence in the setting of active epidermolysis bullosa?
For a patient s/p TORS with indications for adjuvant radiation, how does your management change with persistently elevated ctHPVDNA?
How would the updated results of ECOG 3311 influence your adjuvant RT recommendations for HPV+ OPSCC?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
For a patient with a salivary gland tumor with evidence of local recurrence would you recommend 6 weekly fractions if giving RT alone?
How do you counsel patients regarding alcohol consumption following treatment of head and neck cancer?
How would you approach a patient with synchronous HPV-mediated bilateral tonsil primary with ipsilateral lymph nodes who cannot receive chemotherapy?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
Would you recommend adjuvant radiation for a patient with head/neck merkel cell carcinoma following a pathologic complete response to neoadjuvant immunotherapy?
What is the role for chemo immunotherapy in the up front setting in non-metastatic head & neck cancer outside of clinical trials?
I agree with Dr. @William M. Mendenhall, treat for...